share_log
Reuters ·  Jul 31 06:21
Kexing Biopharm's Albumin-Bound Paclitaxel Granted EU Market Approval
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment